Clinical Trial Update: A Trial of Centanafadine Efficacy and Safety in Children With Attention-deficit/ Hyperactivity Disorder (ADHD) [Phase 3]

View source ↗

Summary

This document reports a completed Phase 3 trial evaluating the efficacy and safety of centanafadine in children with Attention-Deficit/Hyperactivity Disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Centanafadine (centanafadine)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Attention Deficit/Hyperactivity Disorder | Phase 3 | Status: COMPLETED